LEM4 confers tamoxifen resistance to breast cancer cells by activating cyclin D-CDK4/6-Rb and ERα pathway
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LEM4 confers tamoxifen resistance to breast cancer cells by activating cyclin D-CDK4/6-Rb and ERα pathway
Authors
Keywords
-
Journal
Nature Communications
Volume 9, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-10-03
DOI
10.1038/s41467-018-06309-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A subcellular map of the human proteome
- (2017) Peter J. Thul et al. SCIENCE
- Endocrine resistance in hormone-responsive breast cancer: mechanisms and therapeutic strategies
- (2016) Conleth G Murphy et al. ENDOCRINE-RELATED CANCER
- Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
- (2016) Massimo Cristofanilli et al. LANCET ONCOLOGY
- Nuclear envelope rupture drives genome instability in cancer
- (2016) Sanghee Lim et al. MOLECULAR BIOLOGY OF THE CELL
- Palbociclib and Letrozole in Advanced Breast Cancer
- (2016) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- ESCRT III repairs nuclear envelope ruptures during cell migration to limit DNA damage and cell death
- (2016) M. Raab et al. SCIENCE
- Nuclear envelope rupture and repair during cancer cell migration
- (2016) C. M. Denais et al. SCIENCE
- Breast Cancer, Version 1.2016
- (2015) William J. Gradishar et al. Journal of the National Comprehensive Cancer Network
- HOXB7 Is an ER Cofactor in the Activation of HER2 and Multiple ER Target Genes Leading to Endocrine Resistance
- (2015) K. Jin et al. Cancer Discovery
- Targeting CDK4 and CDK6: From Discovery to Therapy
- (2015) C. J. Sherr et al. Cancer Discovery
- Vaccinia-related kinase 1 (VRK1) confers resistance to DNA-damaging agents in human breast cancer by affecting DNA damage response
- (2015) Marcella Salzano et al. Oncotarget
- CDK 4/6 Inhibitor Palbociclib (PD0332991) in Rb+ Advanced Breast Cancer: Phase II Activity, Safety, and Predictive Biomarker Assessment
- (2014) A. DeMichele et al. CLINICAL CANCER RESEARCH
- The mitotic kinase Aurora-A promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα+ breast cancer cells
- (2013) A B D'Assoro et al. ONCOGENE
- Aurora-A is a determinant of tamoxifen sensitivity through phosphorylation of ERα in breast cancer
- (2013) X Q Zheng et al. ONCOGENE
- Role of ERRF, a Novel ER-Related Nuclear Factor, in the Growth Control of ER-Positive Human Breast Cancer Cells
- (2012) Dan Su et al. AMERICAN JOURNAL OF PATHOLOGY
- Coordination of Kinase and Phosphatase Activities by Lem4 Enables Nuclear Envelope Reassembly during Mitosis
- (2012) Claudio Asencio et al. CELL
- The role of S6K1 in ER-positive breast cancer
- (2012) Marina K. Holz CELL CYCLE
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer
- (2011) Suleiman Massarweh et al. BREAST CANCER RESEARCH AND TREATMENT
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Multifactorial Approach to Predicting Resistance to Anthracyclines
- (2011) Christine Desmedt et al. JOURNAL OF CLINICAL ONCOLOGY
- The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway
- (2011) K. Jin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanisms of Endocrine Resistance in Breast Cancer
- (2010) C. Kent Osborne et al. Annual Review of Medicine
- The Mitotic Kinase Aurora-A Induces Mammary Cell Migration and Breast Cancer Metastasis by Activating the Cofilin-F-actin Pathway
- (2010) L.-h. Wang et al. CANCER RESEARCH
- A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population
- (2010) Antonis C Antoniou et al. NATURE GENETICS
- PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer
- (2010) S. Loi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tyrosine phosphorylation of nuclear-membrane protein emerin by Src, Abl and other kinases
- (2009) K. E. Tifft et al. JOURNAL OF CELL SCIENCE
- Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms
- (2009) A Satyanarayana et al. ONCOGENE
- Sixteen-Kinase Gene Expression Identifies Luminal Breast Cancers with Poor Prognosis
- (2008) P. Finetti et al. CANCER RESEARCH
- Cyclin D1 Expression in Breast Cancer Patients Receiving Adjuvant Tamoxifen-Based Therapy
- (2008) M. Rudas et al. CLINICAL CANCER RESEARCH
- S6 Kinase 1 Regulates Estrogen Receptor α in Control of Breast Cancer Cell Proliferation
- (2008) Rachel L. Yamnik et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now